A tiny, electronic device could provide relief to those suffering from rheumatoid arthritis (RA) who want to forego traditional treatment options that are often expensive and can lead to debilitating side effects.
SetPoint Medical, a California-based clinical-stage biomedical technology company, is currently conducting a pilot trial using their new microregulator, an implanted device the size of a coffee bean that could treat RA without needing pills or injectable treatments.